Retcha, Baby Boy .
HRN: 26-58-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2025
AMPICILLIN 250MG (VIAL)
02/25/2025
03/04/2025
IV
100mg
Q12h
Prematurity
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes